US FDA panels to discuss acetaminophen liver toxicity
27 April 2009
Sue Sutter
Please Login to read the full article.
27 April 2009
Sue Sutter
Sue.sutter@informa.com
The US FDA's outside experts will meet in June to discuss measures to reduce the risk of liver injury from prescription and over-the-counter acetaminophen (paracetamol) products.
The FDA said acetaminophen is an important analgesic and antipyretic, and it does not seek to remove the drug...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
- J&J, others dropping infant acetaminophen, as FDA updates OTC liquid med guidelines
- US Capitol Capsule: Group proposes efforts to ensure US innovation competitiveness
- Pfizer may try to take Lipitor OTC, but history is against it
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
